| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Evanson Jeff is a Chief Commercial Officer at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | OTLK Outlook Therapeutics, Inc. | Chief Commercial Officer | Buy | 62,484 | $0.42 | $26,243.28 | +8.4% | -12.5% | -81.9% | |
| Jan 20, 2023 | OTLK Outlook Therapeutics, Inc. | Chief Commercial Officer | Sell | 267,000 | $1.11 | $296,370.00 | -26.4% | +9.2% | -68.0% | |
| Jan 19, 2023 | OTLK Outlook Therapeutics, Inc. | Chief Commercial Officer | Sell | 164,155 | $1.24 | $203,725.82 | -4.8% | -4.2% | -70.9% | |
| Dec 3, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Commercial Officer | Buy | 35,200 | $1.34 | $47,168.00 | +3.1% | +34.6% | -18.8% | |
| Feb 23, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Commercial Officer | Sell | 8,554 | $2.09 | $17,860.75 | -0.7% | - | - | |
| Feb 12, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Commercial Officer | Sell | 56,973 | $2.55 | $145,281.15 | -4.7% | - | - |